279 related articles for article (PubMed ID: 15614521)
1. Recent developments in the management of invasive fungal infections in patients with hematological malignancies.
Karthaus M; Cornely OA
Ann Hematol; 2005 Apr; 84(4):207-16. PubMed ID: 15614521
[TBL] [Abstract][Full Text] [Related]
2. Management of mycoses in patients with hematologic disease and cancer -- review of the literature.
Ruhnke M; Maschmeyer G
Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913
[TBL] [Abstract][Full Text] [Related]
3. [Mycoses and their treatment in malignant hemopathies].
Martino P; Girmenia C
Recenti Prog Med; 1999 Mar; 90(3):160-8. PubMed ID: 10228357
[TBL] [Abstract][Full Text] [Related]
4. Microbiologic consequences of new approaches to managing hematologic malignancies.
Blijlevens NM; Donnelly JP; de Pauw BE
Rev Clin Exp Hematol; 2005 Dec; 9(2):E2. PubMed ID: 16864116
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in antifungal prevention and treatment.
Groll AH; Tragiannidis A
Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
[TBL] [Abstract][Full Text] [Related]
6. Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.
Michallet M; Ito JI
J Clin Oncol; 2009 Jul; 27(20):3398-409. PubMed ID: 19487382
[TBL] [Abstract][Full Text] [Related]
7. [Early diagnosis of invasive fungal infections in hematooncological patients by serological methods].
Rácil Z; Kocmanová I; Wagnerová B; Lengerová M; Mayer J
Vnitr Lek; 2007 Sep; 53(9):990-9. PubMed ID: 18019671
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Cornely OA; Böhme A; Buchheidt D; Glasmacher A; Kahl C; Karthaus M; Kern W; Krüger W; Maschmeyer G; Ritter J; Salwender HJ; Sandherr M; Schiel X; Schüttrumpf S; Sieniawski M; Silling G; Ullmann AJ; Wolf HH;
Ann Hematol; 2003 Oct; 82 Suppl 2():S186-200. PubMed ID: 13680164
[TBL] [Abstract][Full Text] [Related]
9. Invasive fungal infections in children with hematological malignancies: a 5-year study.
Athanassiadou F; Tragiannidis A; Kourti M; Papageorgiou T; Velegraki A; Drevelengas A
Pediatr Hematol Oncol; 2006 Mar; 23(2):163-6. PubMed ID: 16651246
[No Abstract] [Full Text] [Related]
10. Considerations in the approach to invasive fungal infection in patients with haematological malignancies.
Bow EJ
Br J Haematol; 2008 Jan; 140(2):133-52. PubMed ID: 18173752
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary fungal infection with yeasts and pneumocystis in patients with hematological malignancy.
Pagano L; Caira M; Fianchi L
Ann Med; 2005; 37(4):259-69. PubMed ID: 16019724
[TBL] [Abstract][Full Text] [Related]
12. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
[TBL] [Abstract][Full Text] [Related]
13. [Trends of invasive fungal infections in hematological malignancies and new antifungal agents].
Mori T
Rinsho Ketsueki; 2003 Jan; 44(1):8-13. PubMed ID: 12649831
[No Abstract] [Full Text] [Related]
14. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
Maertens J
Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
[TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
16. Management of intracranial fungal infections in patients with haematological malignancies.
Mattiuzzi G; Giles FJ
Br J Haematol; 2005 Nov; 131(3):287-300. PubMed ID: 16225648
[TBL] [Abstract][Full Text] [Related]
17. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003).
Chamilos G; Luna M; Lewis RE; Bodey GP; Chemaly R; Tarrand JJ; Safdar A; Raad II; Kontoyiannis DP
Haematologica; 2006 Jul; 91(7):986-9. PubMed ID: 16757415
[TBL] [Abstract][Full Text] [Related]
18. Second-line treatment in invasive mould infections.
Karthaus M; Cornely OA
Mycoses; 2006; 49 Suppl 1():23-6. PubMed ID: 16961578
[TBL] [Abstract][Full Text] [Related]
19. Changing patterns and trends in systemic fungal infections.
Richardson MD
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i5-i11. PubMed ID: 16120635
[TBL] [Abstract][Full Text] [Related]
20. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
